BR112013015174A2 - compostos de tio-semicarbazona e aplicação no tratamento de cancer - Google Patents

compostos de tio-semicarbazona e aplicação no tratamento de cancer Download PDF

Info

Publication number
BR112013015174A2
BR112013015174A2 BR112013015174-9A BR112013015174A BR112013015174A2 BR 112013015174 A2 BR112013015174 A2 BR 112013015174A2 BR 112013015174 A BR112013015174 A BR 112013015174A BR 112013015174 A2 BR112013015174 A2 BR 112013015174A2
Authority
BR
Brazil
Prior art keywords
cancer
dp4e4mt
fact
compound
treatment
Prior art date
Application number
BR112013015174-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Des R Richardson
David B Lovejoy
Original Assignee
Des R Richardson
David B Lovejoy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010905539A external-priority patent/AU2010905539A0/en
Application filed by Des R Richardson, David B Lovejoy filed Critical Des R Richardson
Publication of BR112013015174A2 publication Critical patent/BR112013015174A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BR112013015174-9A 2010-12-17 2011-12-16 compostos de tio-semicarbazona e aplicação no tratamento de cancer BR112013015174A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010905539 2010-12-17
AU2010905539A AU2010905539A0 (en) 2010-12-17 Dipyridyl Thiosemicarbazone compounds and use in therapy
PCT/AU2011/001631 WO2012079128A1 (en) 2010-12-17 2011-12-16 Thiosemicarbazone compounds and use in the treatment of cancer

Publications (1)

Publication Number Publication Date
BR112013015174A2 true BR112013015174A2 (pt) 2020-08-11

Family

ID=46243892

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013015174-9A BR112013015174A2 (pt) 2010-12-17 2011-12-16 compostos de tio-semicarbazona e aplicação no tratamento de cancer

Country Status (10)

Country Link
US (1) US8927580B2 (https=)
EP (2) EP3287442A1 (https=)
JP (1) JP5883457B2 (https=)
KR (1) KR20140022786A (https=)
CN (1) CN103370308B (https=)
AU (1) AU2011342378B2 (https=)
BR (1) BR112013015174A2 (https=)
CA (1) CA2821984A1 (https=)
NZ (1) NZ613085A (https=)
WO (1) WO2012079128A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2821984A1 (en) 2010-12-17 2012-06-21 Des R. Richardson Thiosemicarbazone compounds and use in the treatment of cancer
WO2014078898A1 (en) * 2012-11-22 2014-05-30 The University Of Sydney Chemotherapy for drug-resistant cancer cells
CN104177288B (zh) * 2013-05-23 2020-05-01 中国人民解放军军事医学科学院毒物药物研究所 缩氨基硒脲衍生物及其药物组合物和用途
US12383518B2 (en) 2013-11-03 2025-08-12 Arizona Board Of Regents On Behalf Of The University Of Arizona Disulfide-masked pro-chelator compositions and methods of use
US11504346B2 (en) 2013-11-03 2022-11-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Redox-activated pro-chelators
SG11201608303QA (en) 2014-04-04 2016-11-29 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
WO2017058748A1 (en) * 2015-09-29 2017-04-06 Oncochel Therapeutics, Llc Thiosemicarbazones
CN109052605A (zh) * 2018-07-26 2018-12-21 雷晓琳 一种重金属捕集剂及其制备方法
CN110698511B (zh) * 2019-11-15 2021-09-14 广西师范大学 以2-吡啶甲醛缩氨基硫脲为配体的锡配合物及其合成方法
KR102555030B1 (ko) * 2020-10-19 2023-07-14 고려대학교 산학협력단 티오세미카바존 유도체 또는 이의 약학적으로 허용가능한 염 및 이의 용도

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4207400A1 (de) * 1992-03-09 1993-09-16 Bayer Ag Hydrazone
WO2004069801A1 (en) 2003-02-05 2004-08-19 Unisearch Limited Metal ion chelators and therapeutic use thereof
AU2003900495A0 (en) * 2003-02-05 2003-02-20 Unisearch Limited Aroylhydrazone derivatives and therapeutic uses thereof
CN1891701A (zh) * 2005-07-07 2007-01-10 桑迪亚医药技术（上海）有限责任公司 杂芳环缩氨基硫脲类化合物及其衍生物和它们在制备抗肿瘤药物中的应用
WO2010000008A1 (en) * 2008-06-30 2010-01-07 Desi Raymond Richardson Thiosemicarbazone compounds and use thereof
CA2821984A1 (en) 2010-12-17 2012-06-21 Des R. Richardson Thiosemicarbazone compounds and use in the treatment of cancer

Also Published As

Publication number Publication date
US8927580B2 (en) 2015-01-06
EP3287442A1 (en) 2018-02-28
CA2821984A1 (en) 2012-06-21
CN103370308B (zh) 2015-06-17
AU2011342378A1 (en) 2013-08-01
AU2011342378B2 (en) 2016-09-01
EP2651894A4 (en) 2014-07-09
EP2651894A1 (en) 2013-10-23
NZ613085A (en) 2015-05-29
JP5883457B2 (ja) 2016-03-15
JP2014502599A (ja) 2014-02-03
CN103370308A (zh) 2013-10-23
EP2651894B1 (en) 2017-08-23
KR20140022786A (ko) 2014-02-25
US20140206725A1 (en) 2014-07-24
WO2012079128A1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
BR112013015174A2 (pt) compostos de tio-semicarbazona e aplicação no tratamento de cancer
CN107257786B (zh) 制备噁噻嗪样化合物的方法
BR122022005149B1 (pt) Compostos com atividade anticâncer, composição farmacêutica que os compreende e seus usos
CZ177596A3 (en) 2,4-disulfonylphenylbutylnitrone, salts thereof and the use of the salts as medicaments
KR102271848B1 (ko) 암 치료용 약학적 배합물
WO2015021929A1 (zh) 异硫氰酸酯类化合物与抗癌药物的联合应用
EP2451273A1 (en) Compositions and methods for inhibition of cancers
US20160022708A1 (en) Methods and compositions for the treatment of glutamine-addicted cancers
CN110248656B (zh) 一种蓝萼甲素衍生物及其药学上可接受的盐或药物组合物及在制备治疗银屑病药物中的用途
ES2877809T3 (es) Terapia combinada para enfermedades proliferativas
US20220348601A1 (en) Ruthenium arene schiff-base complexes and uses thereof
TW202412813A (zh) 含硒元素的查爾酮化合物及其製備方法、包含其的醫藥組合物、以及用於製備預防或治療大腸癌之醫藥組合物的用途
CN110709079B (zh) 包含1，2-萘醌衍生物化合物的实体癌或血液癌的预防或治疗用药物组合物
TWI718608B (zh) 3-(3,5-二溴-4-羥基亞苄基)-5-吲哚基-1,3-二氫吲哚基-2-酮之銨鹽及其用途
CN108299390A (zh) 抗肿瘤化合物dcz0415及其制备方法和应用
JP2025537145A (ja) Ｐａｒ２の低分子調節物質及びその使用
BR112023010742B1 (pt) Uso de derivados de mononucleotídeo de nicotinamida e da composição farmacêutica que os compreende
CN118541368A (zh) 使用bcn057、bcn077及类似物的治疗方法
WO2025253352A1 (en) Methods for promoting hepatic regeneration
CN103755652B (zh) 一种磺酰胺类化合物及其应用
TW202210073A (zh) 一種包含安卓幸醇之組合物用於製備抑制肝癌細胞或肝癌幹細胞生長之藥物的用途
WO2022052055A1 (zh) 一种包含安卓幸醇的组合物用于制备抑制肝癌细胞或肝癌干细胞生长的药物的用途
HK40048076B (zh) 抗癌组合物
WO2015136557A2 (en) Cancer stem cell targeting compounds
US20170022215A1 (en) Compounds for Eradicating or Inhibiting Proliferation of Cancer Stem Cells

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2598 DE 20-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]